Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 3 |
List of Tables | 3 | 1 |
List of Figures | 4 | 1 |
Section 1 - About the Company | 4 | 1 |
Bellerophon Therapeutics Inc - Key Facts | 5 | 1 |
Bellerophon Therapeutics Inc - Key Employees | 6 | 1 |
Bellerophon Therapeutics Inc - Major Products and Services | 7 | 1 |
Bellerophon Therapeutics Inc - History | 8 | 1 |
Bellerophon Therapeutics Inc - Locations And Subsidiaries | 9 | 1 |
Head Office | 9 | 1 |
Section 2 Company Analysis | 10 | 1 |
Company Overview | 10 | 1 |
Bellerophon Therapeutics Inc - Key Competitors | 11 | 1 |
Section 3 Company Financial Ratios | 12 | 1 |
Financial Ratios - Capital Market Ratios | 12 | 1 |
Financial Ratios - Annual Ratios | 13 | 1 |
Performance Chart | 14 | 1 |
Financial Performance | 14 | 1 |
Financial Ratios - Interim Ratios | 15 | 1 |
Financial Ratios - Ratio Charts | 16 | 1 |
Section 4 Company s Lifesciences Financial Deals and Alliances | 17 | 2 |
Bellerophon Therapeutics Inc, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 17 | 1 |
Bellerophon Therapeutics Inc, Pharmaceuticals &Healthcare, Deals By Type, 2010 to YTD 2016 | 18 | 1 |
Bellerophon Therapeutics Inc, Recent Deals Summary | 19 | 1 |
Section 5 Company s Recent Developments | 20 | 1 |
Nov 08, 2016: Bellerophon Reports Third Quarter 2016 Financial Results and Provides Business Update | 20 | 1 |
Sep 20, 2016: Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016 | 21 | 1 |
Aug 09, 2016: Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update | 22 | 1 |
May 10, 2016: Bellerophon Reports First Quarter 2016 Financial Results and Provides Business Update | 23 | 1 |
Mar 21, 2016: Bellerophon Reports 2015 Financial Results and Provides Business Update | 24 | 2 |
Mar 02, 2016: Bellerophon Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) | 26 | 1 |
Feb 23, 2016: Bellerophon Therapeutics Appoints Fabian Tenenbaum as Chief Financial Officer and Chief Business Officer | 27 | 1 |
Feb 16, 2016: Bellerophon Therapeutics Appoints Mary Ann Cloyd as an Independent Board Member | 28 | 1 |
Nov 12, 2015: Bellerophon Reports 2015 Third Quarter Operational and Financial Results | 29 | 1 |
Sep 15, 2015: Bellerophon Therapeutics Announces Leadership Team Changes | 30 | 1 |
Section 6 Appendix | 31 | 5 |
Methodology | 31 | 1 |
Ratio Definitions | 31 | 4 |
About GlobalData | 35 | 1 |
Contact Us | 35 | 1 |
Disclaimer | 35 | 1 |